Skip to content
LongevityGraded

Review

Found Health Review: Weight Loss Only, Billed Every 28 Days

Found's GLP-1 plan is $199 insured or $289 cash on a monthly plan, billed every 28 days. The $99 and $169 it advertises need 12 months paid up front.

Researched & graded by · Lead Reviews Analyst
Last graded
On this page

The one-sentence version

Found Health has the strongest named clinical bench of anything we grade — a former medical director of the American Board of Obesity Medicine, a Columbia endocrinologist, a Stanford psychiatrist-obesity physician — and it states its compounding standard in its own words on its own product pages, which most providers here will not do. It is also, entirely and only, a weight-loss membership: fourteen medications, every one of them for weight loss, and nothing for cognition, energy, longevity or the microbiome. Its compounded GLP-1 plan is $199 a month with insurance or $289 cash on a monthly plan; the $99 and $169 it advertises need twelve months paid up front, and every "monthly" price is billed every 28 days. It grades C, 6 points out of 14. Found is a partner here.

What it is, and what it is not

Found Health, Inc. sells a membership: a licensed clinician reviews an online health assessment, prescribes if appropriate, and your plan covers the care around that. Fourteen medications sit behind it:

  • Injectable GLP-1: compounded semaglutide, compounded tirzepatide, compounded liraglutide, plus brand Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Victoza and Trulicity
  • Oral GLP-1: Foundayo™ (orforglipron) and Rybelsus
  • Oral non-GLP-1: Contrave®, metformin, topiramate and zonisamide

That is the entire list. No NAD+. No sermorelin or any other peptide. No glutathione, no B-12 injection, no methylene blue, no testosterone or hormone replacement, no BPC-157 or TB-500, no supplements, no diagnostics. The only adjacent assets are free calculators and blog posts.

We are saying that plainly because Found is often filed as a longevity-adjacent operator on the strength of metformin appearing on its list. Metformin is on the list — as a weight-loss generic, in a plan Found calls its Generics plan, not as a geroprotector. If metformin is what you are after, what its longevity evidence actually shows is a more useful place to start than a menu.

What it really costs

What Found charges, from its Offer Terms

1 month$199 / $289$89 / $149
3 months$159 / $249$79 / $139
6 months$129 / $219$69 / $129
12 months (= 48 weeks)$99 / $169$49 / $99
From Found's Offer Terms. Every figure is billed every 4 weeks, and its "12 month" term is 48 weeks.

The GLP-1 plan. Found's pricing page reads "Cash plans from $169/mo, insurance plans from $99/mo, billed per 28-day cycle," and its footnote says "Pricing based on 12-month plans paid up-front. Monthly plans start at $199/mo for insurance and $289/mo for cash-pay. Visits for insurance plans may require copays."3 Its binding Offer Terms carry the same compounded-semaglutide table: $199/$289 on one month, $159/$249 on three, $129/$219 on six and $99/$169 on twelve, each covering clinical care, medication and membership. Compounded tirzepatide runs $289/$359 on one month down to $179/$239 on twelve4. New members on a one-month plan get a first-month discount ($99 insured or $179 cash for semaglutide).

The Generics plan. The Offer Terms also price a plan for the oral non-GLP-1 medications at $89 insured or $149 cash on one month, stepping down to $49 and $99 on twelve. That $49 needs both commercial insurance and a twelve-month commitment.

Two traps live in every table. Billing is every 4 weeks, which is 13 cycles a year, not 12 — so a "$199/mo" plan bills $2,587 a year, not $2,388. And Found defines its "12 month" term as 48 weeks, which is about eleven calendar months of coverage for a twelve-month commitment.

Why price transparency scores zero. Our rubric asks for one all-in figure, visible before you commit, that a buyer with no commitment actually pays. Found publishes a great deal of detail, and its pricing page and its binding terms now agree. But every figure is written as "price per month, billed every 4 weeks" — a monthly label on a charge that comes thirteen times a year. We score that the same way for every provider that does it, and it is a zero.

Brand-name prices, for scale: Ozempic about $1,100 a month, Mounjaro about $1,100, Wegovy from $650, Zepbound from $650, Foundayo about $149.

What Found does better than almost anything here

The clinical bench. Found names, with credentials: Dr. Rekha Kumar, MD MS (Senior Medical Advisor, former medical director of the American Board of Obesity Medicine), Dr. Jonathan Larson, MD MBA (Medical Director), Dr. Judith Korner, MD PhD (Columbia), Dr. Shebani Sethi, MD (Stanford) and Dr. Kyu Rhee, MD MPP. It also discloses, in its own words, that Dr. Kumar does not interact directly with Found patients — a caveat most companies would leave you to discover. Naming a bench like that and then volunteering its limit is the kind of disclosure this site exists to reward.

The compounding standard, stated properly. On its compounded-medication product pages Found writes: "Found partners exclusively with 503A-licensed pharmacies — meaning every medication dispensed through Found is compounded by a licensed pharmacist pursuant to your specific prescription, in a facility that must comply with USP standards for sterile preparation."2 That is a claim about who fills your prescription, not a general explanation of the statute, which is the distinction our methodology turns on — so Found takes the full two pharmacy points. What it does not do is name the facility.

Care is inside the plan price. "Every plan includes full access to our licensed medical team, personalized care plans," covering "medical, lifestyle, and behavioral guidance from licensed clinicians" plus a member community. That is a statement about what the money buys, and it earns both the oversight and the support points.

Insurance is real. Found accepts insurance across 41 states, which almost nothing else here does — and for a category that is overwhelmingly cash-pay, that is a material difference to what people actually pay.

The state list, and the two places it argues with itself

Found publishes a 41-state selector for the insurance plans it accepts. On that same page, two contradictions:

  • New Mexico renders an "available plans" panel while being absent from the 41-state selector.
  • California is in the accepted list, yet its own panel reads "No plans available for this state."

Neither is fatal. Both mean the answer you get depends on which control you touched, so confirm your own state before assuming coverage.

Cancellation is the other thing to price in: the membership is refundable only within three days or before your first consult; medications and lab kits are non-refundable once shipped; renewals are non-refundable; and canceling needs 48 hours' notice before the next renewal — which, on a four-week cycle, comes round thirteen times a year.

The evidence, and why it matters that this is GLP-1 and nothing else

Here is the part that cuts in Found's favor, and it is worth stating as clearly as the criticism.

GLP-1 receptor agonists are the only category this site covers with hard outcome data. Semaglutide and tirzepatide have large weight-loss trials behind them, and semaglutide has a cardiovascular-outcomes trial in people with overweight or obesity. Nothing on the compounded longevity shelf — NAD+, sermorelin, glutathione — has evidence of that quality; what the research says about NAD+ is a much thinner story.

So a reader deciding between Found and a compounded NAD+ program is not choosing between longevity and not-longevity. They are choosing between a drug class with cardiovascular-outcome trials and a category without them. What Found cannot do is answer the longevity question most readers here arrive with, because it sells nothing else.

Two caveats belong beside that. Found's compounded semaglutide, tirzepatide and liraglutide are not FDA-approved — FDA's position is that compounded drugs are not FDA-approved and it does not verify their safety, effectiveness or quality before marketing1 — and losing muscle along with fat on GLP-1 therapy is a real clinical concern. Our GLP-1 explainer goes through both.

Before you start

Five things to settle before you join Found

  • Budget the monthly plan: $199 insured or $289 cash. The advertised $99 and $169 need twelve months paid up front.
  • Read the Offer Terms — they bind — and ask whether your insurance adds a visit copay.
  • Count 13 billing cycles a year, not 12 — billing runs every 4 weeks — and note the "12 month" term is 48 weeks.
  • Confirm your state. New Mexico is absent from the 41-state selector but renders a plans panel; California is listed yet its panel says "No plans available for this state".
  • Know the cancellation terms: refundable within 3 days or before the first consult; medications and lab kits non-refundable once shipped; 48 hours' notice to cancel.

Who should use it, and who should not

Use it if weight loss is the goal, insurance is a factor, and you want a named clinical bench and a stated compounding standard behind the prescription. On those terms Found is one of the better-run operators in the category, and the 41-state insurance path is genuinely differentiated.

Skip it if you came here for NAD+, peptides or hormones — it sells none of them and will not start. Skip the $99 and $169 arithmetic unless you are prepared to pay for a year up front that is really 48 weeks. And before you sign anything, read the Offer Terms, because they are the document that binds and they spell out the 28-day billing.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). Found takes two for clinical oversight, because clinician access is stated as inside the plan; two for pharmacy, because it publishes a 503A claim about who fills your prescription on a surface it controls; and two for human support, on published ongoing guidance from licensed clinicians. It takes zero for price transparency, because every "monthly" price is billed every 28 days, and zero for its longevity line, because it has none. Six out of fourteen: a C.

Notice what that is, and what it is not. Found is clean on three of five axes and drops the other two for different reasons — one fixable in an afternoon by labeling its prices per 4 weeks, one structural and permanent unless the company changes what it sells. A provider with no longevity line cannot reach our A band whatever else it does, because the most it can score is ten and the A floor is eleven. That cap is the whole point of the factor: a well-run weight-loss membership should not be able to out-grade a longevity clinic on a page a reader opened to find longevity clinics. If the membership question itself is what you are weighing, concierge versus membership pricing is the better read. The full graded field is at our provider rankings.

Compare Found Health with

We may earn a commission through these links, at no extra cost to you. Disclosure

B

Featured partner

CoreAge Rx $93–$99/mo (starting rates)

Visit CoreAge Rx

See every graded provider ↗

Frequently asked questions

How much does Found Health actually cost?

On the compounded GLP-1 plan, a monthly plan is $199 with insurance or $289 cash, covering clinical care, medication and membership. Longer plans step down to $99 insured or $169 cash on twelve months, paid up front. Compounded tirzepatide is $289 or $359 on one month. The Generics plan for oral non-GLP-1 medications is $89 insured or $149 cash on one month, down to $49 or $99 on twelve. Two things change the arithmetic. Billing runs every four weeks, so a year is thirteen charges rather than twelve — a $199 plan is $2,587 a year, not $2,388. And Found's "12 month" term is 48 weeks, about eleven calendar months of coverage. Insured plans may also add a visit copay.

Is Found's "$99 a month" real?

It is real, and it is the longest plan. $99 a month with insurance, or $169 cash, is the compounded-semaglutide rate on a twelve-month plan paid up front — and Found's twelve months are 48 weeks. A monthly plan is $199 insured or $289 cash, and new members on a one-month plan get a first-month discount to $99 insured or $179 cash. Found's pricing page says this in its own footnote, which is to its credit; just budget from the monthly figure unless you are ready to pay for the year.

Does Found Health sell NAD+, peptides or anything for longevity?

No. Found sells fourteen medications and every one of them is for weight loss: compounded semaglutide, tirzepatide and liraglutide; brand Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Victoza and Trulicity; oral Foundayo (orforglipron) and Rybelsus; and the oral non-GLP-1s Contrave, metformin, topiramate and zonisamide. There is no NAD+, no sermorelin or any other peptide, no glutathione, no B-12 injection, no methylene blue, no testosterone or hormone replacement, no supplements and no diagnostics. Metformin is on the list, but as a weight-loss generic inside the Generics plan rather than as a geroprotector, and Found makes no longevity claim for it. If a compounded longevity line is what you are shopping for, this is not the provider — our rankings grade the ones that sell one.

Who are Found's doctors, and which pharmacy fills the prescription?

Found names its clinical leadership properly, which is rare in this category: Dr. Rekha Kumar, MD MS, Senior Medical Advisor and a former medical director of the American Board of Obesity Medicine; Dr. Jonathan Larson, MD MBA, Medical Director; Dr. Judith Korner, MD PhD, of Columbia; Dr. Shebani Sethi, MD, of Stanford; and Dr. Kyu Rhee, MD MPP. It also volunteers the limit of that, disclosing that Dr. Kumar does not interact directly with Found patients — a caveat most companies would leave you to discover. On the pharmacy, Found states the standard but not the facility: its compounded-medication pages say it "partners exclusively with 503A-licensed pharmacies" and explain what Section 503A requires, which is a claim about who fills your prescription rather than a general note about regulation. No individual pharmacy is named anywhere.

Why does Found Health grade C when it does so much right?

Because it drops both of the double-weighted factors, for two very different reasons. Price transparency scores zero: every figure is labeled per month but billed every four weeks, thirteen charges a year, so no published number is what a month actually costs over a year. The longevity-line factor scores zero because Found sells no longevity medicine at all — fourteen medications, every one for weight loss. Everything else takes full marks: two for clinical oversight, since clinician access is stated as inside the plan price; two for pharmacy, since Found publishes a 503A claim about who fills your prescription on its own product pages; and two for human support, on published ongoing medical, lifestyle and behavioral guidance from licensed clinicians. That is 6 out of 14. Pricing per four weeks instead of per month would take it to 10 — but no further, because a provider with no longevity line cannot reach our A band whatever else it does, and that cap is exactly what the factor exists to enforce.

References

  1. U.S. Food and Drug Administration (2025). Compounding and the FDA: Questions and Answers ('Compounded drugs are not FDA-approved'; 503A pharmacies are not subject to CGMP requirements). FDA — Human Drug Compounding.
  2. Found (2026). Compounded semaglutide — product page ('Found partners exclusively with 503A-licensed pharmacies'). Found website.
  3. Found (2026). Plans and pricing. Found website.
  4. Found (2026). Offer Terms — plan prices, billing cycle and refunds. Found website.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.